Skip to main content

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Biomarcadores en el ictus: optimizando las fases del proceso de traslación, desde el descubrimiento a su uso rutinario

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla
Funding agency: Instituto de Salud Carlos III
Funding: 395670
Reference: PI11/00176
Duration: 01/01/2012 - 30/04/2016

Impacto de la evaluación neurovascular y determinación de biomarcadores en el diagnóstico pre-hospitalario del ictus hiperagudo

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Anna Penalba Morenilla, Maria Pilar Meler Amella
Funding agency: Instituto de Salud Carlos III
Funding: 108075.99
Reference: PI11/01677
Duration: 01/01/2012 - 31/12/2014

Influence of proteases before, during and after stroke (ERANET- PROTEA)

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Maria Pilar Delgado Martínez, Anna Rosell Novel
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 150000
Reference: PRI-PIMNEU-2011-1352 (PROTEA)
Duration: 01/12/2011 - 01/12/2014

Ministerio de Ciencia

GRECAS: genotipando el riesgo y eficacia de clopidogrel o aspirina tras el Ictus; hacia una prevención secundaria personalizada

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 289190
Reference: EC08/00137
Duration: 01/01/2009 - 31/12/2012

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

García Adán, Bernat

García Adán, Bernat

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Paula Granado Martinez

Paula Granado Martinez

Postdoctoral researcher
Biomedical Research in Melanoma
Read more
Piazuelo Espinosa, Sergi

Piazuelo Espinosa, Sergi

Shock, Organ Dysfunction and Resuscitation
Read more
Roberto Vélez Villa

Roberto Vélez Villa

Head of group
Musculoskeletal Tissue Engineering
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.